Differential Aspartate Usage Identifies a Subset of Cancer Cells Particularly Dependent on OGDH

Eric L Allen1, Danielle B Ulanet1, David Pirman1

  • 1Agios Pharmaceuticals, 88 Sidney Street, Cambridge, MA 02139, USA.

Cell Reports
|October 13, 2016
PubMed

Insights

Scientists found that some cancers rely on a specific enzyme, OGDH, for growth. Aspartate levels predict this dependency, offering new targets for cancer drugs.

Area of Science:

  • Biochemistry
  • Oncology
  • Metabolomics

Background:

  • Tumor metabolism is altered, but specific metabolic vulnerabilities in cancer subsets are hard to identify.
  • The tricarboxylic acid (TCA) cycle is crucial for cellular energy production and is often dysregulated in cancer.

Purpose of the Study:

  • To identify cancer cell dependencies on enzymes within the TCA cycle.
  • To explore the role of nutrient utilization in predicting metabolic vulnerabilities for targeted therapies.

Main Methods:

  • Conducted a large-scale siRNA screen targeting enzymes in the TCA cycle.
  • Employed an integrative metabolomics approach to analyze nutrient utilization.
  • Utilized 3D cell culture and xenograft tumor models to assess cancer cell proliferation and growth.

Main Results:

  • Discovered significant cancer cell dependencies on OGDH (alpha-ketoglutarate dehydrogenase complex E1 subunit).
  • Identified differential aspartate utilization, mediated by the malate-aspartate shuttle, as a key predictor of OGDH requirement.
  • Demonstrated that aspartate utilization predicts OGDH dependency for proliferation in 3D cultures and xenograft tumor growth.

Conclusions:

  • Aspartate plays an anaplerotic role, supplying TCA cycle intermediates.
  • Differential nutrient utilization patterns can define cancer subsets with specific metabolic dependencies.
  • These findings suggest potential pharmacological interventions targeting metabolic vulnerabilities in distinct cancer types.